Page: 74
[396] Birkholz provided some general comments on risk assessment on the basis of an
extensive compendium of over 2,000 pages, published by ATSDR, an agency of the United
States Department of Health and Human Services, which sets out the toxicology of various
chemicals, including PCBs. All three expert witnesses referred to this compendium. It was this
document which served as the primary source for Birkholz’s examination of the toxicology of
PCBs in preparation for his testifying in this case. The other Crown expert, Dr. Larry G. Hansen,
was an independent auditor on the compendium, which Birkholz described as “the most
comprehensive [he had] seen on the health effects related to PCBs.”
[397] Birkholz described generally the potential health effects caused by exposure to PCBs,
stating that acute PCB exposures as documented by ATSDR included, for example, various
effects resulting from industrial accidents and explosions, such as increased blood pressure. He
noted that workers who were exposed to “high levels of some of these chemicals” displayed
“very visible effects on the skin such as chloracne,” which, as he explained, was like severe
teenage acne, a form of skin rash. However, Birkholz did not identify, with any certainty, the
specific human health or safety effects one would expect to see based on the level and nature of
the single, acute, dermal exposures evident on the facts of the instant case. Rather, his evidence
was generalized, being founded upon reference to annotations in the ATSDR compendium; with
respect to human health or safety, his testimony was merely descriptive, and not specific to the
persons who were actually exposed and who were called as witnesses in this matter (or others
who might have been in the Stadium at the times of the releases), or with respect to the facts and
factors regarding their presumed exposure.
[398] Notwithstanding that, and the other limitations inherent in his inexperience which I have
already spoken of, Birkholz was asked to provide specific opinions as to whether there was a risk
posed to any of the spectators in the instant case. He did so, in a slightly more specific, but still
general way, by comparing the results of his analysis of the two capacitors he had examined, and
the PCB mixtures in those capacitors, and assuming a 14% dermal absorption rate as set out in a
publication entitled PCB Risk Assessment Review Guidance Document, published by the EPA,
against published recommended tolerable daily intake (“TDI”) levels for PCBs, particularly
those set out by Health Canada.
[399] Birkholz thereby offered the following opinions on risk to human health or safety. First,
as to the Aroclor 1016 contained in the first capacitor he examined, Birkholz opined that Health
Canada’s recommended TDI for a person weighing 70 kilograms would be exceeded if that
person were exposed to the smallest liquid drop of that Aroclor which Birkholz was able to
replicate, and depending upon the instrument used to weigh that Aroclor, by 69 to 74 times. That
was based on an assumption of a 100% concentration of PCBs in the insulating oil. Applying a
70% discount, the TDI is exceeded by 20.7 to 22.2 times.
[400] As to the TEQs of the dioxins and furans which would have been in that liquid drop of
Aroclor 1016 or which would have been produced by the burning or combustion of that same
quantity of Aroclor 1016, Birkholz opined that there was no “adverse risk” to that same person
according to the recommended levels established by the WHO.